23 results on '"Vivenza D"'
Search Results
2. Prognostic value of HPV infection by E1 detection and p16 expression in 78 oropharyngeal squamous cell carcinomas
3. Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer
4. Individual ADCC capability predict treatment outcome under cetuximab-based therapy in head and neck cancer?
5. Tumor-infiltrating lymphocytes (tils) density as prognostic determinant in stage ii colorectal cancer
6. Screening of malignant melanoma (MM) by miRNA: preliminary data on incidence after initial clinical evaluation
7. Prognostic value of hpv infection by e1 detection and p16 expression in 78 oropharyngeal squamous cell carcinomas
8. P-030 Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer
9. Retrospective evaluation of ADCC activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients (mCRC)
10. P-235 Retrospective evaluation of ADCC activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients (mCRC)
11. G5 - Analysis of miRNAs and their correlation with early malignat melanoma (MM)
12. Paclitaxel/Nab-Paclitaxel in Combination with Anti-Angiogenic Therapy: an in Vitro Study
13. 975P - Individual ADCC capability predict treatment outcome under cetuximab-based therapy in head and neck cancer?
14. 976P - Prognostic value of HPV infection by E1 detection and p16 expression in 78 oropharyngeal squamous cell carcinomas
15. 572P - Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer
16. M06 - Screening of malignant melanoma (MM) by miRNA: preliminary data on incidence after initial clinical evaluation
17. L02 - Individual ADCC capability predict treatment outcome under cetuximab-based therapy in head and neck cancer?
18. L05 - Prognostic value of hpv infection by e1 detection and p16 expression in 78 oropharyngeal squamous cell carcinomas
19. D21 - Tumor-infiltrating lymphocytes (tils) density as prognostic determinant in stage ii colorectal cancer
20. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Evolution under Treatment by Cetuximab and Links with Treatment Outcome in Locally Advanced Head and Neck (LAHNSCC) and in Metastatic Colorectal Cancer (MCRC) Patients
21. E14 - Retrospective evaluation of ADCC activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients (mCRC)
22. 1596P - Paclitaxel/Nab-Paclitaxel in Combination with Anti-Angiogenic Therapy: an in Vitro Study
23. 1644PD - Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Evolution under Treatment by Cetuximab and Links with Treatment Outcome in Locally Advanced Head and Neck (LAHNSCC) and in Metastatic Colorectal Cancer (MCRC) Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.